Atlas Trials

Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder

Clinical trial NCT01192568 · COMPLETED

Trial details

NCT number
NCT01192568
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Overactive DetrusorNeurogenic Bladder
Start date
2011-05-17
Primary completion
2023-08-29
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.